Autoantibody-positive (commonly GADA) adult cohorts defined by initial non-insulin-based therapy have previously been described as having latent autoimmune diabetes of adults (LADA), but more recently as having slowly evolving, immune-mediated diabetes of adults [73]. Here, INS is linked to type 1 diabetes mellitus.